Selparin Tablet 1 mg (Rasagiline Mesylate)
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 201908628 · Approved 2019.12.24
This product's status changed to Expired on 2024.12.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of idiopathic Parkinson's disease
This medication is used for the treatment of idiopathic Parkinson's disease. Initially, it is taken alone or in conjunction with dopaminergic agonists to alleviate symptoms. Additionally, it can be used with levodopa in patients experiencing motor fluctuation symptoms, especially during 'end of dose fluctuation,' to improve motor symptoms in patients with Parkinson's disease and enhance their quality of life.
For adults, administer orally once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medicine should not be used by patients who are allergic to this medicine's active ingredient or other components. Patients currently taking or who have recently stopped other MAO inhibitors or certain medications (such as pethidine, tramadol, dextromethorphan) should not take this medicine. Patients with moderate to severe liver dysfunction should not use this medicine, and mild liver impairment should use it with caution. During treatment with this medicine, various side effects such as flu, dermatitis, headache, dizziness, depression, hallucinations, conjunctivitis, rhinitis, and musculoskeletal pain may occur. Especially in patients with Parkinson's disease, caution is required as hallucinations, confusion, and abnormal motor symptoms may occur. This medicine may cause drowsiness or sudden sleep episodes when taken with dopaminergic therapies, so caution is needed when driving or operating hazardous machinery. Additionally, this medication may interact with certain drugs; therefore, patients should consult their physician or pharmacist if they are taking other medications. Pregnant or breastfeeding women should use this medicine with caution, and safety and efficacy in children under 18 years have not been established. In case of overdose, serious side effects may occur, requiring immediate medical attention, as no specific antidote exists; symptomatic treatment should be provided based on the symptoms. Finally, this medicine should be stored out of reach of children, protected from direct sunlight, and stored at a temperature between 1 and 25 degrees Celsius.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain room temperature between 1 and 25 degrees Celsius. Proper storage helps to preserve the medication's effectiveness for a longer period.
Flat round tablet with a white or almost white color and edges
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.